Experimental evidence suggests that low p38 activity in the early stages of cancer may facilitate tumor formation and growth, while increased activation of this pathway in advanced tumor stages may be beneficial (Igea and Nebreda, 2015). This evidence concerns the gene MAPK14 and cancer.